Labels

Monday, June 1, 2015

Immune-Based Drug Shows Potential Against Another Form of Lung Cancer

Patients with squamous cell non-small cell lung cancer who got nivolumab lived longer, had fewer side effects

from WebMD Health http://ift.tt/1KI1x6P
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)